drugset / Trial / NCT04252131

Therapeutic Effect of Cassia Seed in Obesity of Patients With Schizophrenia

NCT04252131 ↗

Phase 1 Completed 92 enrolled Calo Psychiatric Center
RandomizedParallel-groupDouble-blindTreatment

Summary

Schizophrenia patients with anti-psychotics have decreased psychiatric symptoms, but have increased the generation of overweight or obesity. There is correlation between obesity, diabetes mellitus, metabolic syndrome, hypertension, hyperlipidemia and cardiovascular disorders. Cassia seed is one of traditional Chinese herbs, that can decline blood lipedema effect. Therefore, the purpose of the present study was to design a randomized, double blind, control group study to assess the therapeutic effect of Cassia seed in schizophrenia patients with obesity.

Timeline

Start
2018-05-17
Primary completion
2019-10-31
Completion
2019-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject cassia seed tablet Traditional medicine (herbal / TCM) 3 g Oral

Indications